Cartilage Oligomeric Matrix Protein, a Potential Biomarker for Thoracic Aortic Dissection
Khachigian, Levon M., and Golledge, Jonathan (2025) Cartilage Oligomeric Matrix Protein, a Potential Biomarker for Thoracic Aortic Dissection. Jacc Basic to Translational Science, 10 (8). 101346.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (260kB) | Preview |
Abstract
horacic aortic dissection (TAD) is a rare, life-threatening vascular emergency, typically presenting with severe chest or upper back pain. Differentiating TAD from more common causes of chest pain (such as, acute myocardial infarction) can be challenging. 1 Prompt diagnosis and treatment are critical for survival. TAD begins with an initial tear in the intima and media of the aorta and the formation of an alternate channel, or false lumen, and potential rupture. Stanford type A dissections (DeBakey types I and II) involve the ascending aorta, whereas type B dissections (DeBakey type III) involve the descending aorta. Most are the former, which has an in-hospital mortality rate of approximately 30%, and for individuals without surgical intervention, approximately 20% at 24 hours or approximately 50% at 2 weeks after symptom onset. A substantial proportion of aortic dissection patients have recognized connective tissue disease such as Marfan syndrome (MFS), Loeys-Dietz syndrome, and other transforming growth factor β (TGF β )-related syndromes. 1 Vascular smooth muscle cell (SMC) phenotypic switching, matrix metalloproteinase (MMP) expression, and extracellular matrix (ECM) degradation underpin loss of tensile strength and vessel elasticity
| Item ID: | 87850 |
|---|---|
| Item Type: | Article (Editorial) |
| ISSN: | 2452-302X |
| Keywords: | BAPN, biomarker, COMP, Marfan syndrome, thoracic aortic dissection |
| Copyright Information: | © 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed. |
| Date Deposited: | 02 Mar 2026 05:46 |
| FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3201 Cardiovascular medicine and haematology > 320101 Cardiology (incl. cardiovascular diseases) @ 100% |
| SEO Codes: | 20 HEALTH > 2001 Clinical health > 200105 Treatment of human diseases and conditions @ 100% |
| More Statistics |
